Eucalyptus Bio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4M
- Investors
-
7
Eucalyptus Bio General Information
Description
Operator of a clinical company intended to develop gene editing technology for rare diseases. The company's platform directs cells to use error-free rather than error-prone pathways that decrease cellular toxicity to leverage strategic advantage with large edits to develop genetic cures for liver and pancreatic diseases in-house, enabling medical researchers to overcome issues regarding editing genomic deoxyribonucleic acid for therapeutic applications via manipulation of the target cell's repair pathways.
Contact Information
Website
www.crisp-hr.comCorporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Corporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Eucalyptus Bio Timeline
Eucalyptus Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 08-Jan-2024 | $4M | Completed | Pre-Clinical Trials | ||
| 5. Accelerator/Incubator | 13-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC | 14-Sep-2023 | Completed | Product In Beta Test | |||
| 3. Accelerator/Incubator | 20-Mar-2022 | Completed | Startup | |||
| 2. Early Stage VC | 16-Mar-2022 | $1.25M | $1.58M | Completed | Startup | |
| 1. Early Stage VC | 01-Aug-2021 | $330K | $330K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Eucalyptus Bio Comparisons
Industry
Financing
Details
Eucalyptus Bio Competitors (5)
One of Eucalyptus Bio’s 5 competitors is Prime Medicine, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Prime Medicine | Formerly VC-backed | Cambridge, MA | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Ascidian | Venture Capital-Backed | Boston, MA | ||||
| Beam Therapeutics | Formerly VC-backed | Cambridge, MA |
Eucalyptus Bio Patents
Eucalyptus Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023168235-A2 | Systems and methods of gene editing | Inactive | 01-Mar-2022 | ||
| WO-2023168235-A3 | Systems and methods of gene editing | Inactive | 01-Mar-2022 | ||
| EP-4199956-A2 | A nuclease and application thereof | Inactive | 24-Aug-2020 | ||
| WO-2022046669-A2 | A nuclease and application thereof | Inactive | 24-Aug-2020 | ||
| WO-2022046669-A3 | A nuclease and application thereof | Inactive | 24-Aug-2020 | C12N15/1135 |
Eucalyptus Bio Signals
Eucalyptus Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endless Frontier Labs | Accelerator/Incubator | |||
| Illumina Accelerator | Accelerator/Incubator | Minority | ||
| University of California, Santa Barbara | University | Minority | ||
| GCAIA Capital | Angel Group | Minority | ||
| MIT Alumni Angels of Northern California | Angel Group | Minority |
Eucalyptus Bio FAQs
-
When was Eucalyptus Bio founded?
Eucalyptus Bio was founded in 2019.
-
Where is Eucalyptus Bio headquartered?
Eucalyptus Bio is headquartered in San Carlos, CA.
-
What is the size of Eucalyptus Bio?
Eucalyptus Bio has 3 total employees.
-
What industry is Eucalyptus Bio in?
Eucalyptus Bio’s primary industry is Drug Discovery.
-
Is Eucalyptus Bio a private or public company?
Eucalyptus Bio is a Private company.
-
What is Eucalyptus Bio’s current revenue?
The current revenue for Eucalyptus Bio is .
-
How much funding has Eucalyptus Bio raised over time?
Eucalyptus Bio has raised $6.03M.
-
Who are Eucalyptus Bio’s investors?
Endless Frontier Labs, Illumina Accelerator, University of California, Santa Barbara, GCAIA Capital, and MIT Alumni Angels of Northern California are 5 of 7 investors who have invested in Eucalyptus Bio.
-
Who are Eucalyptus Bio’s competitors?
Prime Medicine, CRISPR Therapeutics, Editas Medicine, Ascidian, and Beam Therapeutics are competitors of Eucalyptus Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process